Catalyst Wire Dossier Catalyst Wire Dossier

Orforglipron

orforglipron · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

33 regulatory and trial events tracked for Orforglipron, covering 2024-07-22 to 2026-07-20. Get the full timeline:

Most recent: Clinical Trial Results: A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease [Phase 3]

See pricing